Page last updated: 2024-10-24

regulation of CD4-positive, alpha-beta T cell proliferation

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation. [GOC:obol]

The regulation of CD4+ alpha-beta T cell proliferation is a complex process involving a precise interplay of signaling pathways, transcription factors, and cytokines. These cells, known as helper T cells, play a crucial role in adaptive immunity by recognizing antigen presented by antigen-presenting cells (APCs) via their T cell receptor (TCR). This recognition triggers a cascade of events leading to T cell activation, proliferation, and differentiation into distinct effector subsets.

**1. TCR Signaling and Activation:**

* Antigen presentation by MHC Class II molecules on APCs to the TCR initiates the activation process.
* The TCR complex, along with co-receptors like CD4 and CD28, engages with its ligands on the APC, triggering downstream signaling pathways.
* The key signaling molecules involved include:
* **Lck:** A tyrosine kinase that phosphorylates the ITAMs (immunoreceptor tyrosine-based activation motifs) of the TCR zeta chain.
* **ZAP-70:** A tyrosine kinase that is recruited to the phosphorylated ITAMs and activates downstream signaling cascades.
* **PLC-gamma 1:** A phospholipase that is activated by ZAP-70 and hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol trisphosphate (IP3).
* DAG activates protein kinase C (PKC) and contributes to calcium mobilization.
* IP3 binds to receptors on the endoplasmic reticulum, leading to the release of calcium ions into the cytoplasm.
* Increased intracellular calcium levels activate calcineurin, a phosphatase that dephosphorylates the transcription factor NFAT (nuclear factor of activated T cells).

**2. Transcription Factor Activation and Gene Expression:**

* NFAT translocates to the nucleus and interacts with other transcription factors, including AP-1 and NF-kappaB, to regulate the expression of genes involved in T cell activation and proliferation.
* AP-1 is activated by the MAPK (mitogen-activated protein kinase) pathway, which is initiated by TCR signaling and downstream kinases like ERK (extracellular signal-regulated kinase).
* NF-kappaB is activated by the IKK (IkappaB kinase) complex, which is triggered by TCR signaling and other inflammatory signals.
* The combined activity of these transcription factors promotes the expression of genes encoding cytokines, chemokines, and cell cycle regulators, driving T cell proliferation and differentiation.

**3. Cytokine Signaling and Differentiation:**

* Activated T cells produce a range of cytokines, including IL-2, IL-4, IL-5, IL-6, IFN-gamma, and TNF-alpha.
* **IL-2:** A key autocrine growth factor that promotes the survival and proliferation of activated T cells. IL-2 signaling through its receptor, IL-2R, activates the JAK-STAT pathway and downstream transcription factors, further promoting T cell proliferation.
* **Other cytokines:** These cytokines influence T cell differentiation into distinct subsets with specific effector functions. For example, IL-4 promotes the differentiation of Th2 cells, which produce cytokines like IL-4 and IL-5, involved in humoral immunity. IFN-gamma promotes the differentiation of Th1 cells, which produce IFN-gamma, involved in cell-mediated immunity.

**4. Cell Cycle Regulation and Proliferation:**

* T cell activation and cytokine signaling induce the expression of cell cycle regulators like cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors.
* These proteins control the progression of the cell cycle, allowing for DNA replication and cell division.
* The balance between CDKs and CDK inhibitors determines the rate of T cell proliferation.

**5. Negative Regulation and Immune Tolerance:**

* To prevent excessive immune responses and maintain immune tolerance, T cell proliferation is tightly regulated by negative feedback mechanisms.
* **CTLA-4:** An inhibitory receptor expressed on activated T cells that competes with CD28 for binding to its ligands on APCs, attenuating TCR signaling.
* **PD-1:** Another inhibitory receptor that interacts with its ligands PD-L1 and PD-L2 on APCs, dampening T cell activation and proliferation.
* **Apoptosis:** Activated T cells undergo programmed cell death (apoptosis) after completing their effector functions, contributing to immune homeostasis.

In conclusion, the regulation of CD4+ alpha-beta T cell proliferation is a finely tuned process involving multiple signaling pathways, transcription factors, and cytokines. This intricate regulation ensures a robust and controlled immune response while preventing excessive inflammation and autoimmune disorders. '
"

Proteins (1)

ProteinDefinitionTaxonomy
Interleukin-2An interleukin-2 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P60568]Homo sapiens (human)

Compounds (7)

CompoundDefinitionClassesRoles
daidzindaidzein 7-O-beta-D-glucoside : A glycosyloxyisoflavone that is daidzein attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It is used in the treatment of alcohol dependency (antidipsotropic).

daidzin: a potent, selective, and reversible inhibitor of human mitochondrial aldehyde dehydrogenase
7-hydroxyisoflavones 7-O-beta-D-glucoside;
hydroxyisoflavone;
monosaccharide derivative
plant metabolite
ononin4'-methoxyisoflavones;
7-hydroxyisoflavones 7-O-beta-D-glucoside;
monosaccharide derivative
plant metabolite
formononetin4'-methoxyisoflavones;
7-hydroxyisoflavones
phytoestrogen;
plant metabolite
luteolin-7-glucosideluteolin 7-O-beta-D-glucoside : A glycosyloxyflavone that is luteolin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.

luteolin-7-glucoside: has both antiasthmatic and antineoplastic activities; has 3C protease inhibitory activity; isolated from Ligustrum lucidum
beta-D-glucoside;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone
antioxidant;
plant metabolite
N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamideN(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide : A leucine derivative obtained by fpormal condensation of the secondary amino group of 5-({2,3-dichloro-4-[1-methyl-5-(piperidin-4-yl)-1H-pyrazol-3-yl]phenoxy}methyl)-2-furoic acid and the carboxy group of N-amidino-L-leucylglycineD-leucine derivative;
dichlorobenzene;
furoic acid;
glycine derivative;
guanidines;
pyrazolylpiperidine
calycosin-7-o-beta-d-glucopyranosidecalycosin-7-O-beta-D-glucoside : A glycosyloxyisoflavone that is calycosin substituted by a beta-D-glucopyranosyl residue at position at 7 via a glycosidic linkage.

calycosin-7-O-beta-D-glucoside: from Radix Astragali
4'-methoxyisoflavones;
7-hydroxyisoflavones 7-O-beta-D-glucoside;
hydroxyisoflavone;
monosaccharide derivative
diosgenin glucosidediosgenin 3-O-beta-D-glucoside : A sterol 3-beta-D-glucoside having diosgenin as the sterol component.

diosgenin glucoside: RN given refers to (3beta,25R)-isomer; structure given in first source
hexacyclic triterpenoid;
monosaccharide derivative;
spiroketal;
sterol 3-beta-D-glucoside
metabolite